Leupin Nicolas bought NVCR
February 27, 2024 · Form 4 insider transaction
Leupin Nicolas bought 78,174 shares of NovoCure Limited at $16.30 per share, a transaction worth $1.27M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
78,174
Price
$16.30
Total value
$1.27M
InsiderLeupin Nicolas
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after78,174
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.